Guidelines for Asthma Management in Kenya
(2011; 74 pages)

Abstract

In many low income countries such as Kenya, there are no public supported asthma-care programmes designed to optimize care for patients with asthma which greatly compounds the diagnosis and treatment problems. In 2006, the Kenya Association for the Prevention of Tuberculosis and Lung Disease (KAPTLD) in partnership with the Ministry of Health and the pharmaceutical industry developed a ‘consensus statement’ on the management of asthma in Kenya.

The second edition of the ‘consensus statement’ has been renamed the ‘Kenya national asthma guidelines’ to reflect the purpose for which it has been developed. The primary purpose of this new document is to provide clinicians, researchers, policy makers, health programme developers and managers with a road map to guide the care of individual patients with asthma in Kenya. Secondary objectives are to highlight the need to develop public health care programmes that improve access to asthma care interventions known to positively influence patients’ quality of life and to highlight major gaps in knowledge about asthma in Kenya that research groups can use to develop suitable research studies.

The development of these guidelines was based on the synthesis of international guidelines that are regularly updated such as the Global Initiative for Asthma (GINA) guidelines and the International Union Against Tuberculosis and Lung Disease guidelines for management of asthma in low and middle income countries. These guidelines were extensively reviewed and an attempt made to adopt and adapt them to the Kenyan context.

 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018